Orum Therapeutics Inc
KOSDAQ:475830
Cash Flow Statement
Cash Flow Statement
Orum Therapeutics Inc
| Sep-2025 | ||
|---|---|---|
| Operating Cash Flow | ||
| Net Income |
(31 734)
|
|
| Depreciation & Amortization |
5 191
|
|
| Other Non-Cash Items |
(7 142)
|
|
| Cash Taxes Paid |
(74)
|
|
| Cash Interest Paid |
3 187
|
|
| Change in Working Capital |
(1 985)
|
|
| Cash from Operating Activities |
(35 670)
N/A
|
|
| Investing Cash Flow | ||
| Capital Expenditures |
(1 695)
|
|
| Other Items |
(125 066)
|
|
| Cash from Investing Activities |
(126 761)
N/A
|
|
| Financing Cash Flow | ||
| Net Issuance of Common Stock |
49 305
|
|
| Net Issuance of Debt |
(1 663)
|
|
| Cash from Financing Activities |
47 642
N/A
|
|
| Change in Cash | ||
| Effect of Foreign Exchange Rates |
3 664
|
|
| Net Change in Cash |
(111 125)
N/A
|
|
| Free Cash Flow | ||
| Free Cash Flow |
(37 365)
N/A
|
|